↓ Skip to main content

CD44 splice variant (CD44v3) promotes progression of urothelial carcinoma of bladder through Akt/ERK/STAT3 pathways: novel therapeutic approach

Overview of attention for article published in Journal of Cancer Research & Clinical Oncology, September 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
4 Mendeley
Title
CD44 splice variant (CD44v3) promotes progression of urothelial carcinoma of bladder through Akt/ERK/STAT3 pathways: novel therapeutic approach
Published in
Journal of Cancer Research & Clinical Oncology, September 2019
DOI 10.1007/s00432-019-03024-9
Pubmed ID
Authors

Vivek Anand, Madhuram Khandelwal, Sandeep Appunni, Nidhi Gupta, Amlesh Seth, Prabhjot Singh, Sandeep Mathur, Alpana Sharma

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 4 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 4 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 1 25%
Student > Doctoral Student 1 25%
Student > Postgraduate 1 25%
Unknown 1 25%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 1 25%
Biochemistry, Genetics and Molecular Biology 1 25%
Medicine and Dentistry 1 25%
Unknown 1 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 September 2019.
All research outputs
#7,763,987
of 14,051,039 outputs
Outputs from Journal of Cancer Research & Clinical Oncology
#780
of 1,365 outputs
Outputs of similar age
#126,396
of 261,482 outputs
Outputs of similar age from Journal of Cancer Research & Clinical Oncology
#7
of 32 outputs
Altmetric has tracked 14,051,039 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,365 research outputs from this source. They receive a mean Attention Score of 2.9. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 261,482 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.